Christopher T. Robertson, JD, PhD, reviewed the history and ethical landscape of providing access to drugs before FDA ...

The researchers note that advancements in medical science now allow for the potential exploitation of these “bodyoids.” The conversation echoes a deeper moral dilemma about the definition of humanity ...

The intersection of intellectual property (IP) and genomics is reshaping the landscape of healthcare, biotechnology, and business in Nigeria. Genomics—the study of an organism’s entire genetic ...

Acquisition of approximately 71% stake in Kokomodo Ltd. Acquisition uniquely combines Pluri's mass-scale cell production expertise with Kokomodo Ltd.’s ability to craft real, controlled, ...

NABL issues updated accreditation criteria for biobanks aligned with ISO 20387:2018: Shardul Nautiyal, Mumbai Monday, April ...